NCT04541082 2025-12-18Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsJazz PharmaceuticalsPhase 1 Recruiting102 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT03150862 2025-02-04A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent GlioblastomaBeiGenePhase 1/2 Completed116 enrolled 31 charts
NCT02372006 2021-03-04Trial of Afatinib in Pediatric TumoursBoehringer IngelheimPhase 1/2 Completed56 enrolled 23 charts